株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

陽子線治療の世界市場:2018年~2022年

Global Proton Therapy Market 2018-2022

発行 TechNavio (Infiniti Research Ltd.) 商品コード 316436
出版日 ページ情報 英文 116 Pages
即納可能
価格
本日の銀行送金レート: 1USD=109.81円で換算しております。
Back to Top
陽子線治療の世界市場:2018年~2022年 Global Proton Therapy Market 2018-2022
出版日: 2018年12月20日 ページ情報: 英文 116 Pages
概要

Technavioのアナリストは、世界の陽子線治療市場が2022年までに9%以上のCAGRで成長すると予測しています。

当レポートでは、世界の陽子線治療市場について調査分析し、市場規模と成長率、市場動向、市場促進要因・課題、市場機会について検証するほか、主要ベンダーなどについて、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 レポートの範囲

第3章 調査方法

第4章 市場状況

  • 市場エコシステム
  • 市場の特徴
  • 市場セグメンテーション分析

第5章 市場規模

  • 市場の定義
  • 市場規模(2017年)
  • 市場規模および予測(2017年~2022年)

第6章 ファイブフォース分析

  • バイヤーの交渉力
  • サプライヤーの交渉力
  • 新規参入の脅威
  • 代替品の脅威
  • 競争相手の脅威
  • 市況

第7章 市場セグメンテーション:製品別

  • セグメンテーション:製品別
  • 比較:製品別
  • 装置
  • サービス
  • 市場機会:製品別

第8章 顧客情勢

第9章 地域情勢

  • 地域別セグメンテーション
  • 地域比較
  • 陽子線治療市場:南北アメリカ
  • 陽子線治療市場:欧州・中東・アフリカ地域
  • 陽子線治療市場:アジア太平洋地域
  • 市場機会

第10章 意思決定の枠組み

第11章 成長要因と課題

  • 市場成長要因
  • 市場の課題

第12章 市場動向

  • 技術の進歩
  • 対象症状拡大のための臨床試験数の増加

第13章 ベンダー情勢

  • 概要
  • 創造的破壊の状況

第14章 ベンダー分析

  • 対象ベンダー
  • ベンダー分類
  • ベンダーの市場ポジショニング
  • IBA Worldwide
  • 日立製作所
  • Mevion Medical Systems
  • ProTom International
  • 住友商事
  • Varian Medical Systems

第15章 付録

  • 略語のリスト

第16章 TECHNAVIOについて

図表
  • Exhibit 01: Global radiation oncology market
  • Exhibit 02: Global radiation oncology market - Segments
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global proton therapy market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global proton therapy market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global proton therapy market - Market share by product 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global proton therapy market by equipment - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global proton therapy market by equipment - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Global proton therapy market by services - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global proton therapy market by services - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Global proton therapy market - Market share by region 2017-2022 (%)
  • Exhibit 27: Regional comparison
  • Exhibit 28: Proton therapy market in Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 29: Proton therapy market in Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 30: Top two countries in Americas
  • Exhibit 31: Proton therapy market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 32: Proton therapy market in EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 33: Top two countries in EMEA
  • Exhibit 34: Proton therapy market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 35: Proton therapy market in APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Top two countries in APAC
  • Exhibit 37: Market opportunity
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: IBA Worldwide - Overview
  • Exhibit 44: IBA Worldwide - Business segments
  • Exhibit 45: IBA Worldwide - Organizational developments
  • Exhibit 46: IBA Worldwide - Geographic focus
  • Exhibit 47: IBA Worldwide - Segment focus
  • Exhibit 48: IBA Worldwide - Key offerings
  • Exhibit 49: IBA Worldwide - Key customers
  • Exhibit 50: Hitachi - Overview
  • Exhibit 51: Hitachi - Business segments
  • Exhibit 52: Hitachi - Organizational developments
  • Exhibit 53: Hitachi - Geographic focus
  • Exhibit 54: Hitachi - Segment focus
  • Exhibit 55: Hitachi - Key offerings
  • Exhibit 56: Hitachi - Key customers
  • Exhibit 57: Mevion Medical Systems - Overview
  • Exhibit 58: Mevion Medical Systems - Product segments
  • Exhibit 59: Mevion Medical Systems - Organizational developments
  • Exhibit 60: Mevion Medical Systems - Key offerings
  • Exhibit 61: Mevion Medical Systems - Key customers
  • Exhibit 62: ProTom International - Overview
  • Exhibit 63: ProTom International - Product segments
  • Exhibit 64: ProTom International - Organizational developments
  • Exhibit 65: ProTom International - Key offerings
  • Exhibit 66: ProTom International - Key customers
  • Exhibit 67: Sumitomo Corporation - Overview
  • Exhibit 68: Sumitomo Corporation - Business segments
  • Exhibit 69: Sumitomo Corporation - Organizational developments
  • Exhibit 70: Sumitomo Corporation - Geographic focus
  • Exhibit 71: Sumitomo Corporation - Segment focus
  • Exhibit 72: Sumitomo Corporation - Key offerings
  • Exhibit 73: Sumitomo Corporation - Key customers
  • Exhibit 74: Varian Medical Systems - Overview
  • Exhibit 75: Varian Medical Systems - Business segments
  • Exhibit 76: Varian Medical Systems - Organizational developments
  • Exhibit 77: Varian Medical Systems - Geographic focus
  • Exhibit 78: Varian Medical Systems - Segment focus
  • Exhibit 79: Varian Medical Systems - Key offerings
  • Exhibit 80: Varian Medical Systems - Key customers
目次
Product Code: IRTNTR23860

About this market

The incidence of many cancers such as lung cancer, breast cancer, prostate cancer, colorectal cancer, and stomach cancer is increasing globally. The associated risk factors of cancers are also on the rise. A significant proportion of the risk of cancer incidence is attributed to the high body mass index, poor dietary habits lack of physical activity, tobacco use and alcohol consumption. Technavio's analysts have predicted that the proton therapy market will register a CAGR of over 9% by 2022.

Market Overview

Advantages of proton therapy over standard radiation therapies

Protons can be charged to reach the exact depth where a tumor is located, then stop its further growth. Therefore, proton beams minimize exposure to the nearby healthy tissue surrounding the tumor.

High cost of proton bean therapy and lack of insurance coverage

The high capital costs of proton therapy facilities are restricting their adoption worldwide.

For the detailed list of factors that will drive and challenge the growth of the proton therapy market during the 2018-2022, view our report.

Competitive Landscape

The global proton therapy market is highly concentrated and the market being in a growth phase, the competition among companies is intense. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Equipment
  • Services
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Proton therapy market in Americas
  • Proton therapy market in EMEA
  • Proton therapy market in APAC
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Technological advances
  • Increasing number of clinical trials for indication expansion

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • IBA Worldwide
  • Hitachi
  • Mevion Medical Systems
  • ProTom International
  • Sumitomo Corporation
  • Varian Medical Systems

PART 15: APPENDIX

  • List of abbreviations

PART 16: EXPLORE TECHNAVIO

Back to Top